KRMD
KORU Medical Systems, Inc.NASDAQHealthcare$4.32+1.17%ClosedMarket Cap: $200.3M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
11.54
P/S
4.80
EV/EBITDA
-92.73
DCF Value
$-10.25
FCF Yield
-0.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
60.3%
Operating Margin
-6.7%
Net Margin
-6.4%
ROE
-15.9%
ROA
-9.4%
ROIC
-13.5%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $10.9M | 55.1% | $-547.1K | $-486.9K | $-0.01 | — |
| FY 2025 | $41.1M | 60.3% | $-3.0M | $-2.6M | $-0.06 | — |
| Q3 2025 | $10.4M | 60.2% | $-663.2K | $-778.0K | $-0.02 | — |
| Q2 2025 | $10.2M | 63.5% | $-312.7K | $-206.9K | $-0.00 | — |
| Q1 2025 | $9.6M | 62.8% | $-1.2M | $-1.2M | $-0.03 | — |
| Q4 2024 | $8.8M | 62.9% | $-1.6M | $-1.6M | $-0.03 | — |
| FY 2024 | $33.6M | 63.4% | $-6.4M | $-6.1M | $-0.13 | — |
| Q3 2024 | $8.2M | 63.4% | $-1.7M | $-1.6M | $-0.03 | — |
| Q2 2024 | $8.4M | 65.0% | $-1.2M | $-988.7K | $-0.02 | — |
| Q1 2024 | $8.2M | 62.3% | $-2.0M | $-1.9M | $-0.04 | — |
| Q4 2023 | $7.2M | 60.3% | $-2.2M | $-7.5M | $-0.16 | — |
| FY 2023 | $28.5M | 58.6% | $-10.3M | $-13.7M | $-0.30 | — |